 Connection
Vijaya Knight to Humans
This is a "connection" page, showing publications Vijaya Knight has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.403 |
|
|
|
-
Knight V. Phospho-flow cytometry assays for diagnostic use - A discussion of assay utility and assay development and validation challenges. J Immunol Methods. 2025 Feb; 537:113818.
Score: 0.023
-
Knight V, Starich O, Dutmer CM, Abbott JK. Longitudinal monitoring of class-switched memory-B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders. Cytometry B Clin Cytom. 2025 May; 108(3):222-233.
Score: 0.023
-
Shumate KA, Williams SN, Khatri AB, Knight V. Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel. Cytometry B Clin Cytom. 2024 Sep; 106(5):347-358.
Score: 0.022
-
Knight V, Snyder MR. Editorial introduction for "B cell immunodeficiencies" Journal of Immunological Methods special edition. J Immunol Methods. 2023 08; 519:113505.
Score: 0.021
-
Knight V. Immunodeficiency and Autoantibodies to Cytokines. J Appl Lab Med. 2022 01 05; 7(1):151-164.
Score: 0.019
-
Huey L, Andersen G, Merkel PA, Morrison TE, McCarthy M, DomBourian MG, Annen K, Dawson ED, Rowlen KL, Knight V. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. J Immunol Methods. 2021 10; 497:113104.
Score: 0.018
-
Knight V, Heimall JR, Chong H, Nandiwada SL, Chen K, Lawrence MG, Sadighi Akha AA, Kumánovics A, Jyonouchi S, Ngo SY, Vinh DC, Hagin D, Forbes Satter LR, Marsh RA, Chiang SCC, Willrich MAV, Frazer-Abel AA, Rider NL. A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. J Allergy Clin Immunol Pract. 2021 09; 9(9):3293-3307.e6.
Score: 0.018
-
Taylor SC, Hurst B, Charlton CL, Bailey A, Kanji JN, McCarthy MK, Morrison TE, Huey L, Annen K, DomBourian MG, Knight V. A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection. J Clin Microbiol. 2021 03 19; 59(4).
Score: 0.018
-
Knight V, Askar MZ, Ntrivalas E, Nandiwada SL, Peterson LK, Tebo AE, Kadkhoda K, Schmitz JL, Naides SJ, Snyder MR, Sadighi Akha AA. Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). J Immunol Methods. 2021 05; 492:112994.
Score: 0.018
-
Annen K, Morrison TE, DomBourian MG, McCarthy MK, Huey L, Merkel PA, Andersen G, Schwartz E, Knight V. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors. Transfusion. 2021 04; 61(4):1148-1159.
Score: 0.018
-
Knight V, Long T, Meng QH, Linden MA, Rhoads DD. Variability in the Laboratory Measurement of Cytokines. Arch Pathol Lab Med. 2020 10 01; 144(10):1230-1233.
Score: 0.017
-
DomBourian MG, Annen K, Huey L, Andersen G, Merkel PA, Jung S, Dominguez SR, Knight V. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays. J Immunol Methods. 2020 11; 486:112837.
Score: 0.017
-
Merkel PA, Lebo T, Knight V. Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry. Front Immunol. 2019; 10:1517.
Score: 0.016
-
Knight V. The utility of flow cytometry for the diagnosis of primary immunodeficiencies. Int J Lab Hematol. 2019 May; 41 Suppl 1:63-72.
Score: 0.016
-
Knight V, Wolf ML, Trikha A, Curran-Everett D, Hiserote M, Harbeck RJ. A comparison of specific IgE and skin prick test results to common environmental allergens using the HYTEC? 288. J Immunol Methods. 2018 11; 462:9-12.
Score: 0.015
-
Merkel PA, O'Sullivan MD, Ridge C, Knight V. Critique on the quantitative nature of IgE antibody measurements. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3(6):973-5.
Score: 0.012
-
Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-? autoantibody. Clin Infect Dis. 2014 Mar; 58(6):e115-8.
Score: 0.011
-
Pacheco K, Barker L, Maier L, Erb S, Sills M, Knight V. Development of a validated blood test for nickel sensitization. J Allergy Clin Immunol. 2013 Sep; 132(3):767-769.
Score: 0.010
-
Lim JP, Ahmadian M, Du H, Rickert C, Ghosh T, Xing F, Minic A, Johnson SA, Weinman JP, Willard N, Lin C, Cooper JC, Hanna M, Knight V, Ghosh D, Jordan KR, Hsieh EWY. Precision Medicine in Pediatric Autoimmunity: Leniolisib Treatment of Childhood-Onset Lupus Nephritis Due to Activated Phosphoinositide 3-Kinase d Syndrome. Arthritis Rheumatol. 2025 Nov; 77(11):1596-1604.
Score: 0.006
-
Baxter RM, Cabrera-Martinez B, Ghosh T, Rester C, Moreno MG, Borko TL, Selva S, Fleischer CL, Haakonsen N, Mayher A, Bowhay E, Evans C, Miller TM, Huey L, McWilliams J, van Bokhoven A, Deane KD, Knight V, Jordan KR, Ghosh D, Klarquist J, Kedl RM, Piquet AL, Hsieh EWY. SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis. Immunohorizons. 2024 03 01; 8(3):254-268.
Score: 0.005
-
O'Brien RL, Knight V, Harbeck RJ, Fernández Pérez ER. Alternative assays for identifying the inciting antigen in hypersensitivity pneumonitis. J Allergy Clin Immunol Pract. 2024 May; 12(5):1387-1390.e2.
Score: 0.005
-
O'Brien SC, Cole LD, Albanese BA, Mahon A, Knight V, Williams N, Severson R, Burakoff A, Alden NB, Dominguez SR. SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021. Emerg Infect Dis. 2023 05; 29(5):929-936.
Score: 0.005
-
Chauhan L, Pattee J, Ford J, Thomas C, Lesteberg K, Richards E, Bernas CA, Loi M, Dumont L, Annen K, Berg M, Zirbes M, Knight V, Miller A, Jenkins TC, Bennett TD, Monkowski D, Boxer RS, Beckham JD. A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19. Clin Infect Dis. 2022 08 24; 75(1):e466-e472.
Score: 0.005
-
Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, Crosby K, Deterding RR, Schedel M, Reynolds P, Abbott JK, Knight V, Pittaluga S, Raffeld M, Rosenzweig SD, Bonifacino JS, Uzel G, Williamson PR, Gelfand EW. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Autophagy. 2023 02; 19(2):678-691.
Score: 0.005
-
Abbott JK, Chan SK, MacBeth M, Crooks JL, Hancock C, Knight V, Gelfand EW. Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles. PLoS One. 2022; 17(3):e0265852.
Score: 0.005
-
Windsor WJ, Knight V, Merkel PA, Lamb MM, Tucker HR, Carson K, Howard KM, Yates JL, Santiago ML, McCarthy MK, Morrison TE, Kedl RM, Frazer-Abel A, Guo K, Andersen G, Huey L, Barrett BS, Colón-Franco JM, Lee WT, Chu MC. COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method. Am J Trop Med Hyg. 2022 01 07; 106(2):562-565.
Score: 0.005
-
Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review. Front Immunol. 2021; 12:752856.
Score: 0.005
-
Izadi N, Knight V, Strand M, Hill HR, Peterson LK, Hauk PJ. An enzyme-linked immunospot assay to evaluate Pneumovax response when on intravenous immunoglobulin. Ann Allergy Asthma Immunol. 2022 01; 128(1):61-67.e4.
Score: 0.005
-
Schultz JS, McCarthy MK, Rester C, Sabourin KR, Annen K, DomBourian M, Eisenmesser E, Frazer-Abel A, Knight V, Jaenisch T, Morrison TE, Rochford R, Kedl RM. Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA. J Clin Microbiol. 2021 05 19; 59(6).
Score: 0.005
-
Tacker DH, Bashleben C, Long TC, Theel ES, Knight V, Kadkhoda K, Rhoads DD, Linden MA, Fink SL. Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med. 2021 05 01; 145(5):536-542.
Score: 0.004
-
Dawson ED, Kuck LR, Blair RH, Taylor AW, Toth E, Knight V, Rowlen KL. Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses. J Virol Methods. 2021 05; 291:114111.
Score: 0.004
-
Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A, Oussoren E, Mayr JA, van Spronsen FJ, Lagler FB, Gaughan S, Van Schaftingen E, Veiga-da-Cunha M. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 2020 08 27; 136(9):1033-1043.
Score: 0.004
-
Wang M, Strand MJ, Lanser BJ, Santos C, Bendelja K, Fish J, Esterl EA, Ashino S, Abbott JK, Knight V, Gelfand EW. Expression and activation of the steroidogenic enzyme CYP11A1 is associated with IL-13 production in T cells from peanut allergic children. PLoS One. 2020; 15(6):e0233563.
Score: 0.004
-
Gupta S, Lau K, Harding CO, Shepherd G, Boyer R, Atkinson JP, Knight V, Olbertz J, Larimore K, Gu Z, Li M, Rosen O, Zoog SJ, Weng HH, Schweighardt B. Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 2018 Nov; 37:366-373.
Score: 0.004
-
Castro G, Merkel PA, Giclas HE, Gibula A, Andersen GE, Corash LM, Lin JS, Green J, Knight V, Stassinopoulos A. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease. Transfusion. 2018 06; 58(6):1506-1515.
Score: 0.004
-
Hines SE, Barker EA, Robinson M, Knight V, Gaitens J, Sills M, Duvall K, Rose CS. Cross-Sectional Study of Respiratory Symptoms, Spirometry, and Immunologic Sensitivity in Epoxy Resin Workers. Clin Transl Sci. 2015 Dec; 8(6):722-8.
Score: 0.003
-
Germinaro M, Reynolds P, Knight V, Alam R. Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):82-3.
Score: 0.003
-
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015 Mar; 36(1):1-11.
Score: 0.003
-
Ovrutsky AR, Merkel PA, Schonteich E, Bai X, Kinney W, Iseman MD, Kartalija M, Knight V, Chan ED. Patients with non-tuberculous mycobacterial lung disease have elevated transforming growth factor-beta following ex vivo stimulation of blood with live Mycobacterium intracellulare. Scand J Infect Dis. 2013 Sep; 45(9):711-4.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|